FDA greenlights new coronavirus antigen test
Get all the latest news on coronavirus and more delivered daily to your inbox. Sign up here.
The Food and Drug Administration (FDA) announced Saturday it gave emergency authorization of an antigen test that can quickly detect coronavirus proteins from the swabs of infected patients.
The test, developed by Quidel Corp. in San Diego, Calif., examines samples from the patient’s nasal cavity and is the third type of test to be authorized by the FDA, according to The Associated Press.
The FDA said it expects to authorize similar antigen tests in the future. Quidel claimed its test can provide accurate, automated results in about 15 minutes.
The FDA’s authorization “allows us to arm our health care workers and first responders with a frontline solution for COVID-19 diagnosis, accelerating the time to diagnosis and potential treatment,” Quidel CEO Douglas Bryant said in a statement.